Aleks Alacahan

Aleks Alacahan currently serves as Vice President, Strategy and Commercial Development for Salix Pharmaceuticals. Bringing nearly 20 years of commercial experience within the biopharmaceutical sector and having served as Vice President, US Sales for GI, Key Accounts and Pain divisions, Mr. Alacahan is passionate about the work being done in the healthcare landscape to help provide valuable solutions to the healthcare communities we serve.

Mr. Alacahan joined Salix in 2009, during a pivotal time, helping springboard Salix to being the class-leading GI organization it is today. He played a critical role in the introduction of portfolio-expansion products, including the successful launch of Xifaxan (a non-systemic antibiotic) for hepatic encephalopathy and irritable bowel syndrome (IBS-D). Mr. Alacahan was instrumental in the building, development, and leadership of several specialized sales teams across multiple channels. Prior to Salix, he spent 8 years at DEY Pharmaceuticals, holding various leadership positions in Allergy, Asthma and COPD in the US Market. Mr.

Alacahan earned his Bachelor of Science degree in Business Management from Fairleigh Dickinson University in Madison, NJ and is pursuing his MBA at COX School of Business in Dallas, TX. He is also a member of several distinguished healthcare organizations, striving to advance solutions in the healthcare sector.